We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 6,097

False Claims Act: Circuit Court Questionably Construes Scienter Requirement
  • Jones Day
  • USA
  • June 21 2017

The U.S. Court of Appeals for the Eleventh Circuit recently issued an opinion addressing the False Claims Act's intent requirement. U.S. ex rel. Phalp


“Controlling Employer” Doctrine Reviewed and Vacated by OSHRC Law Judge
  • Seyfarth Shaw LLP
  • USA
  • June 20 2017

In an interesting outcome, an OSHRC Administrative Law Judge recently vacated a citation to an alleged “controlling employer” based on 5th Circuit


PTAB Denies Timely, Relevant Supplement to Petition
  • Jones Day
  • USA
  • June 20 2017

By rule, a petitioner may request permission from the Board to submit supplemental information in an IPR proceeding if: (1) the request is filed


Secrets to Protecting Trade Secrets Abroad
  • Epstein Becker Green
  • USA
  • June 19 2017

Consider the following scenario that was the premise of the book Charlie and the Chocolate Factory (1964), and later adapted into the classic film


A Post-Grant Lesson for Patent Prosecutors
  • Oblon
  • USA
  • June 19 2017

Every so often a decision comes out of the USPTO's Patent Trial & Appeal Board (PTAB) or the Federal Circuit that has immediate value for patent


PTAB Exercised Discretion to Terminate Ex Parte Reexaminations in Ariosa v. Illumina; CAFC to Review
  • Marshall Gerstein & Borun LLP
  • USA
  • June 19 2017

Third parties seeking to challenge pre-AIA patents in the USPTO often choose between IPR and ex parte reexamination. In some cases, petitioners pursue


Safeco Gets Another Safe-NO From Eleventh Circuit on FCA Scienter Standard
  • Vinson & Elkins LLP
  • USA
  • June 16 2017

A recent Eleventh Circuit decision joins the chorus of FCA cases struggling to interpret the scienter requirements in situations where there is more


Specialty Insurance for False Claims Act Investigations: Coverage Gaps Leave Healthcare Providers Exposed and Vulnerable
  • Phelps Dunbar LLP
  • USA
  • June 15 2017

Healthcare providers continue to remain at the greatest risk of having to defend against False Claims Act (FCA) investigations, particularly those


Fifth Circuit Affirms Defense Verdict and Dismissals of Off-Label FCA Claims
  • Sidley Austin LLP
  • USA
  • June 13 2017

Last week, the Fifth Circuit affirmed a defense verdict and the earlier dismissal of several False Claims Act claims related to the alleged off-label


Supreme Court to Review the Constitutionality of AIA Patent Review Proceedings
  • Sterne Kessler Goldstein & Fox
  • USA
  • June 12 2017

Today the Supreme Court granted certiorari in a case that may have profound implications for U.S. patent law by abolishing inter partes reviews at